Please note this is a comparison between Version 1 by Ciara Shortiss and Version 2 by Beatrix Zheng.
Spinal cord injury (SCI) is a devastating trauma that can cause permanent disability, life-long chronic issues for sufferers and is a big socioeconomic burden. Therapies that target multiple different cellular and molecular mechanisms prove to be a superior approach in attempts at regeneration. Studies indicate that a combination of biomaterials and LVs is more effective than either approach alone.
spinal cord injury
gene therapy
lentiviral vector
bioscaffold
biomaterial
Please wait, diff process is still running!
References
NSCISC. National Spinal Cord Injury Statistical Center. Facts and Figures at a Glance; University of Alabama at Birmingham: Birmingham, AL, USA, 2021.
Finnerup, N.B. Neuropathic pain and spasticity: Intricate consequences of spinal cord injury. Spinal Cord 2017, 55, 1046–1050.Finnerup, N.B. Neuropathic pain and spasticity: Intricate consequences of spinal cord injury. Spinal Cord 2017, 55, 1046–1050, doi:10.1038/sc.2017.70.
Binder, H. Chapter 35—Traumatic spinal cord injury. In Handbook of Clinical Neurology; Barnes, M.P., Good, D.C., Eds.; Elsevier: Amsterdam, The Netherlands, 2013; Volume 110, pp. 411–426.
Krause, J.S.; Dismuke-Greer, C.E.; Reed, K.S.; Li, C. Employment status, hours working, and gainful earnings after spinal cord injury: Relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord 2020, 58, 275–283.Krause, J.S.; Dismuke-Greer, C.E.; Reed, K.S.; Li, C. Employment status, hours working, and gainful earnings after spinal cord injury: Relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord 2020, 58, 275–283, doi:10.1038/s41393-019-0374-1.
Ashammakhi, N.; Kim, H.J.; Ehsanipour, A.; Bierman, R.D.; Kaarela, O.; Xue, C.; Khademhosseini, A.; Seidlits, S.K. Regenerative Therapies for Spinal Cord Injury. Tissue Eng. Part B Rev. 2019, 25, 471–491.Ashammakhi, N.; Kim, H.J.; Ehsanipour, A.; Bierman, R.D.; Kaarela, O.; Xue, C.; Khademhosseini, A.; Seidlits, S.K. Regenerative Therapies for Spinal Cord Injury. Tissue Eng. Part B Rev. 2019, 25, 471–491, doi:10.1089/ten.TEB.2019.0182.
O’Shea, T.M.; Burda, J.E.; Sofroniew, M.V. Cell biology of spinal cord injury and repair. J. Clin. Investig. 2017, 127, 3259–3270.O’Shea, T.M.; Burda, J.E.; Sofroniew, M.V. Cell biology of spinal cord injury and repair. J. Clin. Investig. 2017, 127, 3259–3270, doi:10.1172/JCI90608.
Oyinbo, C.A. Secondary injury mechanisms in traumatic spinal cord injury: A nugget of this multiply cascade. Acta Neurobiol. Exp. 2011, 71, 281–299.
Tran, A.P.; Warren, P.M.; Silver, J. The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol. Rev. 2018, 98, 881–917.Tran, A.P.; Warren, P.M.; Silver, J. The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol. Rev. 2018, 98, 881–917, doi:10.1152/physrev.00017.2017.
Alizadeh, A.; Dyck, S.M.; Karimi-Abdolrezaee, S. Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front. Neurol. 2019, 10, 282.Alizadeh, A.; Dyck, S.M.; Karimi-Abdolrezaee, S. Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front. Neurol. 2019, 10, 282, doi:10.3389/fneur.2019.00282.
Bradbury, E.J.; Burnside, E.R. Moving beyond the glial scar for spinal cord repair. Nat. Commun. 2019, 10, 3879.Bradbury, E.J.; Burnside, E.R. Moving beyond the glial scar for spinal cord repair. Nat. Commun. 2019, 10, 3879, doi:10.1038/s41467-019-11707-7.
Uchida, K.; Nakajima, H.; Guerrero, A.R.; Johnson, W.E.B.; Masri, W.E.; Baba, H. Gene therapy strategies for the treatment of spinal cord injury. Ther. Deliv. 2014, 5, 591–607.Uchida, K.; Nakajima, H.; Guerrero, A.R.; Johnson, W.E.B.; Masri, W.E.; Baba, H. Gene therapy strategies for the treatment of spinal cord injury. Ther. Deliv. 2014, 5, 591–607, doi:10.4155/tde.14.20.
Seidlits, S.K.; Gower, R.M.; Shepard, J.A.; Shea, L.D. Hydrogels for lentiviral gene delivery. Expert Opin. Drug Deliv. 2013, 10, 499–509.Seidlits, S.K.; Gower, R.M.; Shepard, J.A.; Shea, L.D. Hydrogels for lentiviral gene delivery. Expert Opin. Drug Deliv. 2013, 10, 499–509, doi:10.1517/17425247.2013.764864.
Milone, M.C.; O’Doherty, U. Clinical use of lentiviral vectors. Leukemia 2018, 32, 1529–1541.Milone, M.C.; O’Doherty, U. Clinical use of lentiviral vectors. Leukemia 2018, 32, 1529–1541, doi:10.1038/s41375-018-0106-0.
Campochiaro, P.A.; Lauer, A.K.; Sohn, E.H.; Mir, T.A.; Naylor, S.; Anderton, M.C.; Kelleher, M.; Harrop, R.; Ellis, S.; Mitrophanous, K.A. Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study. Hum. Gene Ther. 2017, 28, 99–111.Campochiaro, P.A.; Lauer, A.K.; Sohn, E.H.; Mir, T.A.; Naylor, S.; Anderton, M.C.; Kelleher, M.; Harrop, R.; Ellis, S.; Mitrophanous, K.A. Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study. Hum. Gene Ther. 2017, 28, 99–111, doi:10.1089/hum.2016.117.
Thomas, A.M.; Palma, J.L.; Shea, L.D. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries. J. Control. Release 2015, 204, 1–10.Thomas, A.M.; Palma, J.L.; Shea, L.D. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries. J. Control. Release 2015, 204, 1–10, doi:10.1016/j.jconrel.2015.02.032.
Tuinstra, H.M.; Aviles, M.O.; Shin, S.; Holland, S.J.; Zelivyanskaya, M.L.; Fast, A.G.; Ko, S.Y.; Margul, D.J.; Bartels, A.K.; Boehler, R.M.; et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 2012, 33, 1618–1626.Tuinstra, H.M.; Aviles, M.O.; Shin, S.; Holland, S.J.; Zelivyanskaya, M.L.; Fast, A.G.; Ko, S.Y.; Margul, D.J.; Bartels, A.K.; Boehler, R.M.; et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 2012, 33, 1618–1626, doi:10.1016/j.biomaterials.2011.11.002.
Meunier, A.; Pohl, M. Lentiviral vectors for gene transfer into the spinal cord glial cells. Gene Ther. 2009, 16, 476–482.Meunier, A.; Pohl, M. Lentiviral vectors for gene transfer into the spinal cord glial cells. Gene Ther. 2009, 16, 476–482, doi:10.1038/gt.2009.22.
Merten, O.-W.; Hebben, M.; Bovolenta, C. Production of lentiviral vectors. Mol. Ther. Methods Clin. Dev. 2016, 3, 16017.Merten, O.-W.; Hebben, M.; Bovolenta, C. Production of lentiviral vectors. Mol. Ther. Methods Clin. Dev. 2016, 3, 16017–16017, doi:10.1038/mtm.2016.17.
Nori, S.; Khazaei, M.; Ahuja, C.S.; Yokota, K.; Ahlfors, J.-E.; Liu, Y.; Wang, J.; Shibata, S.; Chio, J.; Hettiaratchi, M.H.; et al. Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury. Stem Cell Rep. 2018, 11, 1433–1448.Nori, S.; Khazaei, M.; Ahuja, C.S.; Yokota, K.; Ahlfors, J.-E.; Liu, Y.; Wang, J.; Shibata, S.; Chio, J.; Hettiaratchi, M.H.; et al. Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury. Stem Cell Rep. 2018, 11, 1433–1448, doi:10.1016/j.stemcr.2018.10.017.
Wang, D.; Li, J.; Tran, K.; Burt, D.R.; Zhong, L.; Gao, G. Slow Infusion of Recombinant Adeno-Associated Viruses into the Mouse Cerebrospinal Fluid Space. Hum. Gene Ther. Methods 2018, 29, 75–85.Wang, D.; Li, J.; Tran, K.; Burt, D.R.; Zhong, L.; Gao, G. Slow Infusion of Recombinant Adeno-Associated Viruses into the Mouse Cerebrospinal Fluid Space. Hum. Gene Ther. Methods 2018, 29, 75–85, doi:10.1089/hgtb.2017.250.
Kimura, E.; Li, S.; Gregorevic, P.; Fall, B.M.; Chamberlain, J.S. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression. Mol. Ther. 2010, 18, 206–213.Kimura, E.; Li, S.; Gregorevic, P.; Fall, B.M.; Chamberlain, J.S. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression. Mol. Ther. 2010, 18, 206–213, doi:10.1038/mt.2009.253.
Vranckx, L.S.; Demeulemeester, J.; Debyser, Z.; Gijsbers, R. Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras. PLoS ONE 2016, 11, e0164167.Vranckx, L.S.; Demeulemeester, J.; Debyser, Z.; Gijsbers, R. Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras. PLoS ONE 2016, 11, e0164167, doi:10.1371/journal.pone.0164167.
Schröder, A.R.W.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J.R.; Bushman, F. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots. Cell 2002, 110, 521–529.Schröder, A.R.W.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J.R.; Bushman, F. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots. Cell 2002, 110, 521–529, doi:10.1016/S0092-8674(02)00864-4.
Das, A.T.; Tenenbaum, L.; Berkhout, B. Tet-On Systems For Doxycycline-inducible Gene Expression. Curr. Gene Ther. 2016, 16, 156–167.Das, A.T.; Tenenbaum, L.; Berkhout, B. Tet-On Systems For Doxycycline-inducible Gene Expression. Curr. Gene Ther. 2016, 16, 156–167, doi:10.2174/1566523216666160524144041.
Blits, B.; Bunge, M.B. Direct Gene Therapy for Repair of the Spinal Cord. J. Neurotrauma 2006, 23, 508–520.Blits, B.; Bunge, M.B. Direct Gene Therapy for Repair of the Spinal Cord. J. Neurotrauma 2006, 23, 508–520, doi:10.1089/neu.2006.23.508.
Kruzik, A.; Fetahagic, D.; Hartlieb, B.; Dorn, S.; Koppensteiner, H.; Horling, F.M.; Scheiflinger, F.; Reipert, B.M.; de la Rosa, M. Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors. Mol. Ther. Methods Clin. Dev. 2019, 14, 126–133.Kruzik, A.; Fetahagic, D.; Hartlieb, B.; Dorn, S.; Koppensteiner, H.; Horling, F.M.; Scheiflinger, F.; Reipert, B.M.; de la Rosa, M. Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors. Mol. Ther. Methods Clin. Dev. 2019, 14, 126–133, doi:10.1016/j.omtm.2019.05.014.
Annoni, A.; Gregori, S.; Naldini, L.; Cantore, A. Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell. Immunol. 2019, 342, 103802.Annoni, A.; Gregori, S.; Naldini, L.; Cantore, A. Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell. Immunol. 2019, 342, 103802, doi:10.1016/j.cellimm.2018.04.012.
Trono, D. Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther 2000, 7, 20–23.Trono, D. Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther 2000, 7, 20–23, doi:10.1038/sj.gt.3301105.
Loy, D.N.; Crawford, C.H.; Darnall, J.B.; Burke, D.A.; Onifer, S.M.; Whittemore, S.R. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 2002, 445, 308–324.Loy, D.N.; Crawford, C.H.; Darnall, J.B.; Burke, D.A.; Onifer, S.M.; Whittemore, S.R. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 2002, 445, 308–324, doi:10.1002/cne.10168.
Haggerty, A.E.; Maldonado-Lasunción, I.; Oudega, M. Biomaterials for revascularization and immunomodulation after spinal cord injury. Biomed. Mater. 2018, 13, 044105.Haggerty, A.E.; Maldonado-Lasunción, I.; Oudega, M. Biomaterials for revascularization and immunomodulation after spinal cord injury. Biomed. Mater. 2018, 13, 044105, doi:10.1088/1748-605X/aaa9d8.
Koichi, M.; Noriko, M.; Takashi, S. Gene Delivery into the Central Nervous System (CNS) Using AAV Vectors; IntechOpen: London, UK, 2015.Koichi, M.; Noriko, M.; Takashi, S. Gene Delivery into the Central Nervous System (CNS) Using AAV Vectors; IntechOpen: London, UK 2015, doi:10.5772/61638.
Leibinger, M.; Zeitler, C.; Gobrecht, P.; Andreadaki, A.; Gisselmann, G.; Fischer, D. Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice. Nat. Commun. 2021, 12, 391.Leibinger, M.; Zeitler, C.; Gobrecht, P.; Andreadaki, A.; Gisselmann, G.; Fischer, D. Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice. Nat. Commun. 2021, 12, 391–391, doi:10.1038/s41467-020-20112-4.
Stepankova, K.; Jendelova, P.; Machova Urdzikova, L. Planet of the AAVs: The Spinal Cord Injury Episode. Biomedicines 2021, 9, 613.Stepankova, K.; Jendelova, P.; Machova Urdzikova, L. Planet of the AAVs: The Spinal Cord Injury Episode. Biomedicines 2021, 9, 613, doi:10.3390/biomedicines9060613.
Liu, S.; Xie, Y.-Y.; Wang, B. Role and prospects of regenerative biomaterials in the repair of spinal cord injury. Neural Regen. Res. 2019, 14, 1352–1363.Liu, S.; Xie, Y.-Y.; Wang, B. Role and prospects of regenerative biomaterials in the repair of spinal cord injury. Neural Regen. Res. 2019, 14, 1352–1363, doi:10.4103/1673-5374.253512.
Wu, H.F.; Cen, J.S.; Zhong, Q.; Chen, L.; Wang, J.; Deng, D.Y.; Wan, Y. The promotion of functional recovery and nerve regeneration after spinal cord injury by lentiviral vectors encoding Lingo-1 shRNA delivered by Pluronic F-127. Biomaterials 2013, 34, 1686–1700.Wu, H.F.; Cen, J.S.; Zhong, Q.; Chen, L.; Wang, J.; Deng, D.Y.; Wan, Y. The promotion of functional recovery and nerve regeneration after spinal cord injury by lentiviral vectors encoding Lingo-1 shRNA delivered by Pluronic F-127. Biomaterials 2013, 34, 1686–1700, doi:10.1016/j.biomaterials.2012.11.013.
Padmashali, R.M.; Andreadis, S.T. Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels. Biomaterials 2011, 32, 3330–3339.Padmashali, R.M.; Andreadis, S.T. Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels. Biomaterials 2011, 32, 3330–3339, doi:10.1016/j.biomaterials.2011.01.035.
Shin, S.; Shea, L.D. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol. Ther. 2010, 18, 700–706.Shin, S.; Shea, L.D. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol. Ther. 2010, 18, 700–706, doi:10.1038/mt.2009.300.
Thomas, A.M.; Gomez, A.J.; Palma, J.L.; Yap, W.T.; Shea, L.D. Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors. Biomaterials 2014, 35, 8687–8693.Thomas, A.M.; Gomez, A.J.; Palma, J.L.; Yap, W.T.; Shea, L.D. Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors. Biomaterials 2014, 35, 8687–8693, doi:10.1016/j.biomaterials.2014.06.027.
Thomas, A.M.; Shea, L.D. Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury. J. Control. Release Off. J. Control. Release Soc. 2013, 170, 421–429.Thomas, A.M.; Shea, L.D. Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury. J. Control. Release Off. J. Control. Release Soc. 2013, 170, 421–429, doi:10.1016/j.jconrel.2013.06.013.
Shrimali, P.; Peter, M.; Singh, A.; Dalal, N.; Dakave, S.; Chiplunkar, S.V.; Tayalia, P. Efficient in situ gene delivery via PEG diacrylate matrices. Biomater. Sci. 2018, 6, 3241–3250.Shrimali, P.; Peter, M.; Singh, A.; Dalal, N.; Dakave, S.; Chiplunkar, S.V.; Tayalia, P. Efficient in situ gene delivery via PEG diacrylate matrices. Biomater. Sci. 2018, 6, 3241–3250, doi:10.1039/C8BM00916C.
Shin, S.; Tuinstra, H.M.; Salvay, D.M.; Shea, L.D. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 2010, 31, 4353–4359.Shin, S.; Tuinstra, H.M.; Salvay, D.M.; Shea, L.D. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 2010, 31, 4353–4359, doi:10.1016/j.biomaterials.2010.02.013.
McMahon, S.S.; Nikolskaya, N.; Choileáin, S.N.; Hennessy, N.; O’Brien, T.; Strappe, P.M.; Gorelov, A.; Rochev, Y. Thermosensitive hydrogel for prolonged delivery of lentiviral vector expressing neurotrophin-3 in vitro. J. Gene Med. 2011, 13, 591–601.McMahon, S.S.; Nikolskaya, N.; Choileáin, S.N.; Hennessy, N.; O’Brien, T.; Strappe, P.M.; Gorelov, A.; Rochev, Y. Thermosensitive hydrogel for prolonged delivery of lentiviral vector expressing neurotrophin-3 in vitro. J. Gene Med. 2011, 13, 591–601, doi:10.1002/jgm.1613.
Stilhano, R.S.; Madrigal, J.L.; Wong, K.; Williams, P.A.; Martin, P.K.M.; Yamaguchi, F.S.M.; Samoto, V.Y.; Han, S.W.; Silva, E.A. Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle. J. Control. Release 2016, 237, 42–49.Stilhano, R.S.; Madrigal, J.L.; Wong, K.; Williams, P.A.; Martin, P.K.M.; Yamaguchi, F.S.M.; Samoto, V.Y.; Han, S.W.; Silva, E.A. Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle. J. Control. Release 2016, 237, 42–49, doi:10.1016/j.jconrel.2016.06.047.
Skoumal, M.; Seidlits, S.; Shin, S.; Shea, L. Localized lentivirus delivery via peptide interactions. Biotechnol. Bioeng. 2016, 113, 2033–2040.Skoumal, M.; Seidlits, S.; Shin, S.; Shea, L. Localized lentivirus delivery via peptide interactions. Biotechnol. Bioeng. 2016, 113, 2033–2040, doi:10.1002/bit.25961.
Croyle, M.A.; Callahan, S.M.; Auricchio, A.; Schumer, G.; Linse, K.D.; Wilson, J.M.; Brunner, L.J.; Kobinger, G.P. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J. Virol. 2004, 78, 912–921.Croyle, M.A.; Callahan, S.M.; Auricchio, A.; Schumer, G.; Linse, K.D.; Wilson, J.M.; Brunner, L.J.; Kobinger, G.P. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J. Virol. 2004, 78, 912–921, doi:10.1128/jvi.78.2.912-921.2004.
Munis, A.M.; Mattiuzzo, G.; Bentley, E.M.; Collins, M.K.; Eyles, J.E.; Takeuchi, Y. Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery. Mol. Ther. Nucleic Acids 2019, 17, 126–137.Munis, A.M.; Mattiuzzo, G.; Bentley, E.M.; Collins, M.K.; Eyles, J.E.; Takeuchi, Y. Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery. Mol. Ther. Nucleic Acids 2019, 17, 126–137, doi:10.1016/j.omtn.2019.05.010.
Croyle, M.A.; Yu, Q.-C.; Wilson, J.M. Development of a Rapid Method for the PEGylation of Adenoviruses with Enhanced Transduction and Improved Stability under Harsh Storage Conditions. Hum. Gene Ther. 2000, 11, 1713–1722.Croyle, M.A.; Yu, Q.-C.; Wilson, J.M. Development of a Rapid Method for the PEGylation of Adenoviruses with Enhanced Transduction and Improved Stability under Harsh Storage Conditions. Hum. Gene Ther. 2000, 11, 1713–1722, doi:10.1089/10430340050111368.
Jang, J.-H.; Schaffer, D.V.; Shea, L.D. Engineering biomaterial systems to enhance viral vector gene delivery. Mol. Ther. 2011, 19, 1407–1415.Jang, J.-H.; Schaffer, D.V.; Shea, L.D. Engineering biomaterial systems to enhance viral vector gene delivery. Mol. Ther. 2011, 19, 1407–1415, doi:10.1038/mt.2011.111.
Dalamagkas, K.; Tsintou, M.; Seifalian, A.; Seifalian, A.M. Translational Regenerative Therapies for Chronic Spinal Cord Injury. Int. J. Mol. Sci. 2018, 19, 1776.Dalamagkas, K.; Tsintou, M.; Seifalian, A.; Seifalian, A.M. Translational Regenerative Therapies for Chronic Spinal Cord Injury. Int. J. Mol. Sci. 2018, 19, 1776, doi:10.3390/ijms19061776.
Liu, M.; Huang, C.; Zhao, Z.; Wang, A.; Li, P.; Fan, Y.; Zhou, G. Nano-hydroxyapatite(n-HA) involved in the regeneration of rat nerve injury triggered by overloading stretch. Med. Nov. Technol. Devices 2019, 4, 100022.Liu, M.; Huang, C.; Zhao, Z.; Wang, A.; Li, P.; Fan, Y.; Zhou, G. Nano-hydroxyapatite(n-HA) involved in the regeneration of rat nerve injury triggered by overloading stretch. Med. Nov. Technol. Devices 2019, 4, 100022, doi:10.1016/j.medntd.2019.100022.
Taraballi, F.; Sushnitha, M.; Tsao, C.; Bauza, G.; Liverani, C.; Shi, A.; Tasciotti, E. Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials. Adv. Healthc. Mater. 2018, 7, 1800490.Taraballi, F.; Sushnitha, M.; Tsao, C.; Bauza, G.; Liverani, C.; Shi, A.; Tasciotti, E. Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials. Adv. Healthc. Mater. 2018, 7, 1800490, doi:10.1002/adhm.201800490.
Ribeiro-Samy, S.; Silva, N.A.; Correlo, V.M.; Fraga, J.S.; Pinto, L.; Teixeira-Castro, A.; Leite-Almeida, H.; Almeida, A.; Gimble, J.M.; Sousa, N. Development and characterization of a PHB-HV-based 3 D scaffold for a tissue engineering and cell-therapy combinatorial approach for spinal cord injury regeneration. Macromol. Biosci. 2013, 13, 1576–1592.
Cho, Y.; Shi, R.; Borgens, R.B. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J. Exp. Biol. 2010, 213, 1513.Cho, Y.; Shi, R.; Borgens, R.B. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J. Exp. Biol. 2010, 213, 1513, doi:10.1242/jeb.035162.
Shin, S.; Salvay, D.M.; Shea, L.D. Lentivirus delivery by adsorption to tissue engineering scaffolds. J. Biomed. Mater. Res. A 2010, 93, 1252–1259.Shin, S.; Salvay, D.M.; Shea, L.D. Lentivirus delivery by adsorption to tissue engineering scaffolds. J. Biomed. Mater. Res. A 2010, 93, 1252–1259, doi:10.1002/jbm.a.32619.
Bushnell, G.G.; Rao, S.S.; Hartfield, R.M.; Zhang, Y.; Oakes, R.S.; Jeruss, J.S.; Shea, L.D. Microporous scaffolds loaded with immunomodulatory lentivirus to study the contribution of immune cell populations to tumor cell recruitment in vivo. Biotechnol. Bioeng. 2020, 117, 210–222.Brunger, J.M.; Huynh, N.P.T.; Guenther, C.M.; Perez-Pinera, P.; Moutos, F.T.; Sanchez-Adams, J.; Gersbach, C.A.; Guilak, F. Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. Proc. Natl. Acad. Sci. USA 2014, 111, E798-E806, doi:10.1073/pnas.1321744111.
Ciciriello, A.J.; Smith, D.R.; Munsell, M.K.; Boyd, S.J.; Shea, L.D.; Dumont, C.M. IL-10 lentivirus-laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury. Biotechnol. Bioeng. 2021, 118, 2609–2625.Bushnell, G.G.; Rao, S.S.; Hartfield, R.M.; Zhang, Y.; Oakes, R.S.; Jeruss, J.S.; Shea, L.D. Microporous scaffolds loaded with immunomodulatory lentivirus to study the contribution of immune cell populations to tumor cell recruitment in vivo. Biotechnol. Bioeng. 2020, 117, 210–222, doi:10.1002/bit.27179.
Brunger, J.M.; Huynh, N.P.T.; Guenther, C.M.; Perez-Pinera, P.; Moutos, F.T.; Sanchez-Adams, J.; Gersbach, C.A.; Guilak, F. Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. Proc. Natl. Acad. Sci. USA 2014, 111, E798–E806.Schlegel, R.; Tralka, T.S.; Willingham, M.C.; Pastan, I. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? Cell 1983, 32, 639–646, doi:10.1016/0092-8674(83)90483-x.
Higashikawa, F.; Chang, L.-J. Kinetic Analyses of Stability of Simple and Complex Retroviral Vectors. Virology 2001, 280, 124–131.Boddohi, S.; Moore, N.; Johnson, P.A.; Kipper, M.J. Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan. Biomacromolecules 2009, 10, 1402–1409, doi:10.1021/bm801513e.
Shepard, J.A.; Virani, F.R.; Goodman, A.G.; Gossett, T.D.; Shin, S.; Shea, L.D. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 2012, 33, 7412–7421.Bart, J.; Tiggelaar, R.; Yang, M.; Schlautmann, S.; Zuilhof, H.; Gardeniers, H. Room-temperature intermediate layer bonding for microfluidic devices. Lab Chip 2009, 9, 3481–3488, doi:10.1039/b914270c.
Ehsanipour, A.; Sathialingam, M.; Rad, L.M.; de Rutte, J.; Bierman, R.D.; Liang, J.; Xiao, W.; Di Carlo, D.; Seidlits, S.K. Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord. APL Bioeng. 2021, 5, 016104.Ciciriello, A.J.; Smith, D.R.; Munsell, M.K.; Boyd, S.J.; Shea, L.D.; Dumont, C.M. IL-10 lentivirus-laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury. Biotechnol. Bioeng. 2021, 118, 2609–2625, doi:10.1002/bit.27781.
Ehsanipour, A.; Nguyen, T.; Aboufadel, T.; Sathialingam, M.; Cox, P.; Xiao, W.; Walthers, C.M.; Seidlits, S.K. Injectable, Hyaluronic Acid-Based Scaffolds with Macroporous Architecture for Gene Delivery. Cell. Mol. Bioeng. 2019, 12, 399–413.Higashikawa, F.; Chang, L.-J. Kinetic Analyses of Stability of Simple and Complex Retroviral Vectors. Virology 2001, 280, 124–131, doi:10.1006/viro.2000.0743.
Kidd, M.E.; Shin, S.; Shea, L.D. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J. Control. Release 2012, 157, 80–85.Shepard, J.A.; Virani, F.R.; Goodman, A.G.; Gossett, T.D.; Shin, S.; Shea, L.D. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 2012, 33, 7412–7421, doi:10.1016/j.biomaterials.2012.06.081.
Gros, T.; Sakamoto, J.S.; Blesch, A.; Havton, L.A.; Tuszynski, M.H. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials 2010, 31, 6719–6729.Ehsanipour, A.; Sathialingam, M.; Rad, L.M.; de Rutte, J.; Bierman, R.D.; Liang, J.; Xiao, W.; Di Carlo, D.; Seidlits, S.K. Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord. APL Bioeng. 2021, 5, 016104–016104, doi:10.1063/5.0035291.
Smith, D.R.; Dumont, C.M.; Park, J.; Ciciriello, A.J.; Guo, A.; Tatineni, R.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model. Tissue Eng. Part A 2020, 26, 672–682.Ehsanipour, A.; Nguyen, T.; Aboufadel, T.; Sathialingam, M.; Cox, P.; Xiao, W.; Walthers, C.M.; Seidlits, S.K. Injectable, Hyaluronic Acid-Based Scaffolds with Macroporous Architecture for Gene Delivery. Cell. Mol. Bioeng. 2019, 12, 399–413, doi:10.1007/s12195-019-00593-0.
Smith, D.R.; Margul, D.J.; Dumont, C.M.; Carlson, M.A.; Munsell, M.K.; Johnson, M.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Combinatorial lentiviral gene delivery of pro-oligodendrogenic factors for improving myelination of regenerating axons after spinal cord injury. Biotechnol. Bioeng. 2019, 116, 155–167.Gros, T.; Sakamoto, J.S.; Blesch, A.; Havton, L.A.; Tuszynski, M.H. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials 2010, 31, 6719–6729, doi:10.1016/j.biomaterials.2010.04.035.
Tuinstra, H.M.; Margul, D.J.; Goodman, A.G.; Boehler, R.M.; Holland, S.J.; Zelivyanskaya, M.L.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Long-Term Characterization of Axon Regeneration and Matrix Changes Using Multiple Channel Bridges for Spinal Cord Regeneration. Tissue Eng. Part A 2013, 20, 1027–1037.Smith, D.R.; Dumont, C.M.; Park, J.; Ciciriello, A.J.; Guo, A.; Tatineni, R.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model. Tissue Eng. Part A 2020, 26, 672–682, doi:10.1089/ten.tea.2019.0321.
Smith, D.R.; Margul, D.J.; Dumont, C.M.; Carlson, M.A.; Munsell, M.K.; Johnson, M.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Combinatorial lentiviral gene delivery of pro-oligodendrogenic factors for improving myelination of regenerating axons after spinal cord injury. Biotechnol. Bioeng. 2019, 116, 155–167, doi:10.1002/bit.26838.
Kidd, M.E.; Shin, S.; Shea, L.D. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J. Control. Release 2012, 157, 80–85, doi:10.1016/j.jconrel.2011.08.036.
Tuinstra, H.M.; Margul, D.J.; Goodman, A.G.; Boehler, R.M.; Holland, S.J.; Zelivyanskaya, M.L.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Long-Term Characterization of Axon Regeneration and Matrix Changes Using Multiple Channel Bridges for Spinal Cord Regeneration. Tissue Eng. Part A 2013, 20, 1027–1037, doi:10.1089/ten.tea.2013.0111.